Stakeholders’ Consulting Group

Stakeholders’ Consulting Group

ICE-HBV collaborates with key stakeholders to accelerate research in HBV cure. ICE-HBV Stakeholders’ Consulting Group gathers them annually to provide input on the development of ICE-HBV global research roadmap, share information about HBV cure programmes and identify potential synergies and collaborations areas.

The Stakeholders’ Consulting Group provides advice to researchers working towards the discovery of a safe, affordable, scalable and effective Hepatitis B cure.

The group is working on the following three pillars of HBV Cure preparedness, to ensure the timely and effective transition of research discoveries:

The Group is co-chaired by Timothy Block (Hepatitis B Foundation), Veronica Miller (HBV Forum) and Ulrike Protzer (DZIF).

Current Members:

Alex Ng, Bill and Melinda Gates Foundation (Beijing)

Anna Kramvis, University of the Witwatersrand

Benjamin Cowie,  WHO Collaborating Centre for Viral Hepatitis at Doherty Institute

Brian McMahon, World Indigenous Peoples’ Conference on Viral Hepatitis

Cecil K. Dovia, Cedaku Foundation/Ghana Health Centre

Christian Bréchot, Global Virus Network

Chris Muñoz, Yellow Warriors Society Philippines

David Hutton, University of Michigan

Dee Lee, Inno Community Development China

Emma Day,  Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)

Fernando Contreras, ALEH

Finlay Macrae, World Gastroenterology Organization

François Dabis, ANRS

Francesco Marinucci, FIND

Giten Khwairakpam, TreatAsia

Greg Dore, Kirby Institute

Harry Janssen, International Symposium on Viral Hepatitis and Liver Disease (ISVHLD)

Helen Tyrell, Hepatitis Australia

Homie Razavi, CDA Foundation

Jack Wallace, Burnet Institute/CEVHAP

Jeffrey V. Lazarus, Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona

Jennifer Johnston, CEVHAP

Jinlin Hou, Nanfang Hospital, Southern Medical University

John Ward, Task Force for Global Health

Manal El-Sayed, Ain Shams University

Marc Bulterys, Global Hepatitis Programme, HIV/Hepatitis Department, World Health Organization

Marinela Debu, ELPA

Maud Lemoine, MRC Gambia/Prolifica

Mehlika Toy, Asian Liver Centre at Stanford University

Michael Ninburg, Hepatitis Education Project

Rajen Koshi, National Institute of Allergy and Infectious Diseases

Raquel Peck, World Hepatitis Alliance

Rosmawati Mohammed, CEVHAP

Samuel So, Asian Liver Centre at Stanford University

Saeed Hamid, CEVHAP

Silvana Lesidrenka, ELPA

Su Wang, World Hepatitis Alliance

Timothy Block, Hepatitis B Foundation

Ulrike Protzer, DZIF

Veronica Miller, HBV Forum

Ventzislava Petrov-Sanchez, ANRS

Wangsheng Li, EndHep2030 and Zeshan Foundation

William Phelps,  American Cancer Society, Inc.

Stakeholders Consulting Group ToRs – V2 April 2018